| Serial Number | 97169506 |
| Word Mark | SUPPORTING THE DEVELOPMENT OF POTENTIAL CURES |
| Filing Date | Monday, December 13, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 2, 2023 |
| Registration Number | 7040283 |
| Registration Date | Tuesday, May 2, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 14, 2023 |
| Goods and Services | Financial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products |
| Goods and Services | Assistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations |
| Goods and Services | Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases |
| Goods and Services | Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 16, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, December 9, 2021 |
| First Use In Commerce Date | Thursday, December 9, 2021 |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 16, 2021 |
| Primary Code | 036 |
| First Use Anywhere Date | Thursday, December 9, 2021 |
| First Use In Commerce Date | Thursday, December 9, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 16, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, December 9, 2021 |
| First Use In Commerce Date | Thursday, December 9, 2021 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 16, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | Thursday, December 9, 2021 |
| First Use In Commerce Date | Thursday, December 9, 2021 |
| Party Name | HYBRID CONCEPTS INTERNATIONAL, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | GRAND ISLAND, NY 14072 |
| Party Name | HYBRID CONCEPTS INTERNATIONAL, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | GRAND ISLAND, NY 14072 |
| Party Name | HYBRID CONCEPTS INTERNATIONAL, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | GRAND ISLAND, NY 14072 |
| Event Date | Event Description |
| Tuesday, May 2, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 2, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 14, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 14, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 25, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, January 9, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 28, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 27, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 27, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 17, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 17, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, November 17, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, November 11, 2022 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, October 4, 2022 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Tuesday, September 20, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, September 19, 2022 | ASSIGNED TO EXAMINER |
| Thursday, December 16, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 16, 2021 | NEW APPLICATION ENTERED |